Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology. Matracell removes a minimum of 97% of donor DNA, allowing for rapid cellular infiltration and re-vascularization. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration.
Matrion is the first decellularized, full-thickness placental membrane designed to act as a protective barrier to support wound healing. Unlike bi-layer Placental Membranes, Matrion includes a decellularized trophoblast layer. The trophoblast layer is up to four times thicker than both the amniotic and chorionic membranes and includes native biologic factors that are missing in traditional bi-layer membranes.
- Product Information
- Clinical Resources
ARTICLE IN REVIEW: Dermacell AWM in the treatment of large diabetic foot ulcers with exposed tendon and bone.ARTICLE IN REVIEW: Greater healing using DermACELL AWM versus conventional care to treat venous leg ulcers.ARTICLE IN REVIEW: A randomized clinical trial of DermACELL AWM in the treatment of diabetic foot ulcers.
- Additional Media